Yichao Bu
4PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 24, 2025
Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma.Shiguang Yang, Shaoqing Liu, Jie Li
|Oct 01, 2025
Targeting JMJD6/PPARĪ³/GPX4 axis overcomes ferroptosis resistance and enhances therapeutic efficacy in hepatocellular carcinoma.Jie Li, Shengwei Mao, Shiguang Yang
|Jul 22, 2025
Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma.Tianhao Chu, Guiqi Zhu, Zheng Tang
|May 02, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma.Wei-Feng Qu, Gui-Qi Zhu, Rui Yang
Pageof 1
Frequent Collaborators
3 joint publications
Yinghong Shi
2 joint publications
Guiqi Zhu
2 joint publications
Jian Zhou
2 joint publications
Jia Fan
2 joint publications
Weiren Liu
1 joint publications
Wei-Feng Qu
1 joint publications
Rui Yang
1 joint publications
Tian-Hao Chu
1 joint publications
Zhi-Qi Guan
1 joint publications
Qian-Fu Zhao
